Prognostic factors in patients with carcinoma of the uterine cervix treated with external beam irradiation and IR-192 high-dose-rate brachytherapy

International Journal of Radiation Oncology Biology Physics

Volumn 42, Issue 3, 1998, Pages 531-540

  Kapp, Karin S ^a   Stuecklschweiger, Georg F ^a   Kapp, Daniel S ^b   Poschauko, Johann ^a   Pickel, Hellmuth ^a   Lahousen, Manfred ^a   Hackl, Arnulf ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cervical carcinoma; High dose rate brachytherapy; Prognostic factors; Radiation therapy

Indexed keywords

HEMOGLOBIN; IRIDIUM 192;

ADULT; AGED; ARTICLE; BEAM THERAPY; BRACHYTHERAPY; CANCER STAGING; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; RADIATION DOSE; TREATMENT OUTCOME; TUMOR VOLUME; UTERINE CERVIX CARCINOMA;

EID: 0031724728     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00255-7     Document Type: Article

References (66)

1. Piver MS, Chung WS. Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma. Obstet Gynecol 1975; 46:507-510.
2. Potish RA, Twiggs LB, Okagaki T, et al. Therapeutic implications of the natural history of advanced cervical cancer as defined by pretreatment surgical staging. Cancer 1985; 56: 956-960.
3. Lee YN, Wang KL, Lin MH, et al. Radical hysterectomy with pelvic lymph node dissection for treatment of cervical cancer: A clinical review of 954 cases. Gynecol Oncol 1989; 32:135-142.
4. Alvarez RD, Potter ME, Soong SJ, et al. Rationale for using pathologic tumor dimensions and nodal status to subclassify surgically treated stage IB cervical cancer patients. Gynecol Oncol 1991; 43:108-112.
5. Burghardt E, Baltzer J, Tulusan H, et al. Results of surgical treatment of 1028 cervical cancers studied with volumetry. Cancer 1992; 70:648-655.
6. Kamura T, Tsukamoto N, Tsuruchi N, et al. Multivariate analysis of histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy. Cancer 1992; 69:181-186.
7. Pickel H, Haas J, Lahousen M. Prognostic factors in cervical cancer. Eur J Obstet Gynecol Reprod Biol 1997; 71:209-213.
8. Perez CA, Zivnuska F, Askin F, et al. Prognostic significance of endometrial extension from primary carcinoma of the uterine cervix. Cancer 1975; 35:1493-1504.
9. Kapp DS, Fischer D, Gutierrez E, et al. Pretreatment prognostic factors in carcinoma of the uterine cervix: A multivariate analysis of the effect of age stage histology and blood counts on survival. Int J Radiat Oncol Biol Phys 1983; 9:445-455.
10. Benstead K, Cowie VJ, Blair V, et al. Stage III carcinoma of the cervix. The importance of increasing age and extent of parametrial infiltration. Radiother Oncol 1986; 5:271-276.
11. Lanciano RM, Won M, Coia LR, et al. Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: A final report of the 1973 and 1978 patterns of care study. Int J Radiat Oncol Biol Phys 1991; 20:667-676.
12. Stehman FB, Bundy BN, DiSaia PJ, et al. Carcinoma of the cervix treated with radiation therapy. I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer 1991; 67:2776-2785.
13. Fagundes H, Perez CA, Grigsby PW, et al. Distant metastases after irradiation alone in carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1992; 24:197-204.
14. Werner-Wasik M, Schmid CH, Bornstein L, et al. Prognostic factors for local and distant recurrence in stage I and II cervical carcinoma. Int J Radiat Oncol Biol Phys 1995; 32: 309-317.
15. Prempree T, Patanaphan V, Sewchand W, et al. The influence of patient's age and tumor grade on the prognosis of carcinoma of the cervix. Cancer 1983; 51:1764-1771.
16. Sinistrero G, Sismondi P, Zola P. Results of treatment of uterine cervix cancer by radiotherapy. Radiother Oncol 1988; 13:257-265.
17. Dattoli MJ, Gretz HF III, Beller U, et al. Analysis of multiple prognostic factors in patients with stage IB cervical cancer: Age as a major determinant. Int J Radiat Oncol Biol Phys 1989; 17:41-47.
18. Lowrey GC, Mendenhall WM, Million RR. Stage IB or IIA-B carcinoma of the intact uterine cervix treated with irradiation: A multivariate analysis. Int J Radiat Oncol Biol Phys 1992; 24:205-210.
19. Fyles AW, Pintilie M, Kirkbride P, et al. Prognostic factors in patients with cervix cancer treated by radiation therapy: Results of multiple regression analysis. Radiother Oncol 1995; 35:107-117.
20. Pedersen D, Sogaard H, Overgaard J, et al. Prognostic value of pretreatment factors in patients with locally advanced carcinoma of the uterine cervix treated by radiotherapy alone. Acta Oncol 1995; 34:787-795.
21. Barillot I, Horiot JC, Pigneux J, et al. Carcinoma of the intact uterine cervix treated with radiotherapy alone: A French Cooperative Study: Update and multivariate analysis of prognostic factors. Int J Radiat Oncol Biol Phys 1997; 38:969-978.
22. Ashby MA, Smales E. Invasive carcinoma of the cervix in young women: Clinical data and prognostic features. Radiother Oncol 1987; 10:167-174.
23. Perez CA, Grigsby PW, Nene SM, et al. Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone. Cancer 1992; 69:2796-2806.
24. Eifel PJ, Morris M, Wharton TJ, et al. The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1994; 29:9-16.
25. Grigsby PW, Perez CA, Kuske RR, et al. Adenocarcinoma of the uterine cervix: Lack of evidence for a poor prognosis. Radiother Oncol 1988; 12:289-296.
26. Eifel PJ, Burke TW, Morris M, et al. Adenocarcinoma as an independent risk factor for disease recurrence in patients with Stage IB cervical carcinoma. Gynecol Oncol 1995; 59:3-44.
27. Evans JC, Bergsjo P. The influence of anemia on the results of radiotherapy in carcinoma of the cervix. Radiology 1965; 84:709-716.
28. Vigario G, Kurohara SS, George FW III. Association of hemoglobin levels before and during radiotherapy with prognosis in uterine cervix cancer. Radiology 1973; 106:649-652.
29. Dische S, Anderson PJ. Carcinoma of the cervix-anemia radiotherapy and hyperbaric oxygen. Br J Radiol 1983; 56:251-255.
30. Bush RS. The significance of anemia in clinical radiation therapy. Int J Radiat Oncol Biol Phys 1986; 12:2047-2050.
31. Girinsky T, Pejovic-Lenfant MH, Bourhis J, et al. Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: Results of a retrospective study of 386 patients. Int J Radiat Oncol Biol Phys 1989; 16:37-42.
32. Hopkins MP, Morley GW. Prognostic factors in advanced stage squamous cell cancer of the cervix. Cancer 1993; 72: 2389-2393.
33. Delaloye JF, Coucke PA, Pampallona S, et al. Effect of total treatment time on event-free survival in carcinoma of the cervix. Gynecol Oncol 1996; 60:42-48.
34. Fyles A, Keane TJ, Barton M, et al. The effect of treatment duration in the local control of cervix cancer. Radiother Oncol 1992; 25:273-279.
35. Girinsky T, Rey A, Roche B, et al. Overall treatment time in advanced cervical carcinomas: A critical parameter in treatment outcome. Int J Radiat Oncol Biol Phys 1993; 27:1051-1056.
36. Lanciano RM, Pajak TF, Martz K, et al. The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: A patterns-of-care study. Int J Radiat Oncol Biol Phys 1993; 25:391-397.
37. Teshima T, Chatani M, Hata K, et al. High-dose rate intracavitary therapy for carcinoma of the uterine cervix. I. General figures of survival and complications. Int J Radiat Oncol Biol Phys 1987; 13:1035-1041.
38. Busch M II, Dühmke E, Kuhn W, et al. Definitive radiation therapy in the treatment of carcinoma of the uterine cervix. Treatment results and prognostic factors. Strahlenther Onkol 1991; 167:628-637.
39. Hong J-H, Chen M-S, Lin F-J, et al. Prognostic assessment of tumor regression after external beam irradiation for cervical cancer. Int J Radiat Oncol Biol Phys 1992; 22:913-917.
40. Selke P, Roman TN, Souhami L, et al. Treatment results of high dose rate brachytherapy in patients with carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1993; 27:803-809.
41. Chatani M, Matayoshi Y, Masaki N, et al. Long term follow-up results of high-dose rate remote afterloading intracavitary radiation therapy for carcinoma of the uterine cervix. Strahlenther Onkol 1994; 170:269-276.
42. Ito H, Kutuki S, Nishiguchi I, et al. Radiotherapy for cervical cancer with high-dose rate brachytherapy - correlation between tumor size dose and failure. Radiother Oncol 1994; 31:240-247.
43. Pechoux C, Akine Y, Sumi M, et al. High dose rate brachytherapy for carcinoma of the uterine cervix: Comparison of two different fractionation regimens. Int J Radiat Oncol Biol Phys 1995; 31:735-741.
44. Petereit DG, Sarkaria JN, Chappell R, et al. The adverse effect of treatment prolongation in cervical carcinoma. Int J Radiat Oncol Biol Phys 1995; 32:1301-1307.
45. Toita T, Nakano M, Higashi M, et al. Prognostic value of cervical size and pelvic lymph node status assessed by computed tomography for patients with uterine cervical cancer treated by radical radiation therapy. Int J Radiat Oncol Biol Phys 1995; 33:843-849.
46. Abitbol AA, Wolfson AH, Lewin AA, et al. Management of stage I-B, II-A, and II-B carcinoma of the cervix with high-dose-rate brachytherapy: Initial results of an institutional clinical trial. Am J Clin Oncol 1996; 19:223-228.
47. Chatani M, Matayoshi Y, Masaki N, et al. High-dose rate intracavitary irradiation for carcinoma of the uterine cervix the adverse effect of treatment prolongation. Strahlenther Onkol 1997; 173:379-384.
48. Ogino I, Okamoto N, Andoh K, et al. Analysis of prognostic factors in stage IIB-IVA cervical carcinoma treated with radiation therapy: Value of computed tomography. Int J Radiat Oncol Biol Phys 1997; 37:1071-1077.
49. Spiessl B, Beahrs OH, Hermanek P, et al., eds. Union Internationale Contre le Cancer. TNM and FIGO classification of malignant tumours. 3rd ed. Springer Verlag; 1992.
50. Kapp KS, Stuecklschweiger G, Kapp D, et al. Dosimetry of intracavitary placements for uterine and cervical carcinoma: Results of orthogonal film TLD and CT-assisted techniques. Radiother Oncol 1992; 24:137-146.
51. Kaplan EL, Meier P. Non-parametric estimations from incomplete observations. J Am Stat Assoc 1953; 53:457-480.
52. Cox DR. Regression models and life tables. J Royal Stat Soc 1972; 34(Series B):187-220.
53. Eifel PJ. High-dose-rate brachytherapy for carcinoma of the cervix: High tech or high risk? Int J Radiat Oncol Biol Phys 1992; 24:383-386.
54. Kapp KS, Stuecklschweiger G, Kapp DS, et al. Carcinoma of the cervix: Analysis of complications after primary external beam irradiation and Ir-192 HDR brachytherapy. Radiother Oncol 1997; 42:143-153.
55. Hall EJ, Bedford JS, Oliver R. Extreme hypoxia: Its effect on the survival of mammalian cells irradiated at high and low-dose rates. Br J Radiol 1966; 39:302-307.
56. Berry RJ. Hypoxic protection and recovery in tumour cells irradiated at low dose-rates and assessed in vivo. Br J Radiol 1968; 41:921-926.
57. Hall EJ. The OER at low dose rates. Br J Radiol 1977; 50:373-374.
58. Spiro IJ, Ling CC, Stickler R, et al. Oxygen radiosensitisation at low dose rate. Br J Radiol 1985; 58:357-363.
59. Hricak H, Quivey JM, Campos Z, et al. Carcinoma of the cervix: Predictive value of clinical and magnetic resonance (MR) imaging asessment of prognostic factors. Int J Radiat Oncol Biol Phys 1993; 27:791-801.
60. Camilien L, Gordon D, Fruchter RG, et al. Predictive value of computerized tomography in the presurgical evaluation of primary carcinoma of the cervix. Gynecol Oncol 1998; 30: 209-215.
61. Kim SH, Choi BI, Lee HP, et al. Uterine cervical carcinoma: Comparison of CT and MR findings. Radiology 1990; 175: 45-51.
62. Mottram JC, Eidinow A. On the effect of anemia on the reactions of the skin and of tumors to radium exposure. Br J Surg 1932; 19:481-487.
63. Hirst DG. Anemia: A problem or an opportunity in radiotherapy? Int J Radiat Oncol Biol Phys 1986; 12:2009-2017.
64. Inoue T, Morita K. Significance of number of positive nodes in cervical carcinoma Stages IB IIA and IIB. Cancer 1990; 65:1923-1927.
65. Scheidler J, Hricak H, Yu KK, et al. Radiological evaluation of lymph node metastases in patients with cervix cancer. JAMA 1997; 278:1096-1101.
66. Fowler JF, Lindstrom MJ. Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys 1992; 23:457-467.